Identification and Characterization of a Novel Gene, C13orf25, as a Target for 13q31-q32 Amplification in Malignant Lymphoma

Cancer Research

Volumn 64, Issue 9, 2004, Pages 3087-3095

  Ota, Akinobu ^a   Tagawa, Hiroyuki ^a   Karnan, Sivasundaram ^a   Tsuzuki, Shinobu ^a   Karpas, Abraham ^b   Kira, Shigeki ^c   Yoshida, Yasuko ^c   Seto, Masao ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NGK INSULATORS LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B CELL LYMPHOMA; C13ORF25 GENE; CHROMOSOME 13; CHROMOSOME 13Q; CHROMOSOME MAP; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EXPRESSED SEQUENCE TAG; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC CONSERVATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; OPEN READING FRAME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNTRANSLATED REGION;

AMINO ACID SEQUENCE; BLOTTING, NORTHERN; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 13; EXTRACELLULAR MATRIX PROTEINS; GENE AMPLIFICATION; GLYPICANS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MOLECULAR SEQUENCE DATA; NUCLEIC ACID HYBRIDIZATION; OPEN READING FRAMES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 2342449399     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3773     Document Type: Article

References (34)

1. Schwab M. Oncogene amplification in solid tumors. Semin Cancer Biol 1999;9:319-25.
2. Schwab M. Amplification of N-Myc as a prognostic marker for patients with neuroblastoma. Semin Cancer Biol 1993;4:13-8.
3. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-MYC in untreated human neuroblastomas correlates with advanced diseased stage. Science (Wash. DC) 1984;224:1121-4.
4. Slamon DJ, Clark G, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-82.
5. Rao PH, Houldsworth J, Dyomina K, et al. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 1998;92:234-40.
6. Monni O, Oinonen R, Elonen E, et al. Gain of 3q and deletion of 11q22 are frequant abverrations in mantle cell lymphoma Genes Chromosomes Cancer 1998;21:298-307.
7. Neat MJ, Foot N, Jenner M, et al. Localization of novel region of recurrent amplification in follicular lymphoma to an ∼6.8 Mb region of 13q32-33. Genes Chromosomes Cancer 2001;32:236-43.
8. Mao X, Lillington D, Child F, Russell-Jones R, Young B, Whittaker S. Comparative genomic hybridization analysis of primary cutaneous B-cell lymphoma: identification of common genomic alterations in disease pathogenesis. Genes Chromosomes Cancer 2002;35:144-55.
9. Ko YH, Choi KE, Han JH, Kim JM, Ree HJ. Comparative genomic hybridization stud of nasal-type NK/T-cell lymphoma. Cytometry 2001;46:85-91.
10. Knuutila S, Bjorkqvist A-M, Autio K, et al. DNA copy number amplifications in human neoplasms. Am J Pathol 1998;152:1107-23.
11. Schmidt H, Wurl P, Taubert H, et al. Genomic imbalances of 7p and 17q in malignant peripheral nerve sheath tumors are clinically relevant. Genes Chromosomes Cancer 1999;25:205-11.
12. Lallamendy ML, Tarkkanen M, Blomqvist C, et al. Compatative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol 1997;151:1153-61.
13. Gordon AT, Brinkschmidt C, Anderson J, et al. A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 2000;28:220-6.
14. Karnan S, Tagawa H, Suzuki R, et al. Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 2004;39:77-81.
15. Yu W, Inoue J, Imoto I, Matsuo Y, Karpas A, Inazawa J. GPC5 is a possible target for the 13q31-q32 amplification detected in lymphoma cell lines. J Hum Genet 2003;48:331-5.
16. Solinas-Toldo S, Lampel S, Stilgenbauer S, et al. Matrix-based comparative genomic hybridization: biochip to screen for genomic imbalance. Genes Chromosomes Cancer 1997;20:399-407.
17. Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarray. Nat Genet 1998;23:41-6.
18. Martinez-Climent JA, Alizadeh AA, Segraves R, et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set DNA copy number and gene expression alterations. Blood 2003;101:3109-17.
19. Martinez-Climent JA, Vizcarra E, Sanchez D, et al. Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma Blood 2001;98:3479-82.
20. Dyer MJ, Fischer P, Nacheva E, Labastide W, Karpas A. A new human B-cell non-Hodgkin's lymphoma cell line (Karpas 422) exhibiting both t(14;18) and t(4;11) chromosomal translocations. Blood 1990;75:709-14.
21. Naoe T, Akao Y, Yamada K, et al. Cytogenetic characterization of a T-cell line, ATN-1, derived from adult T-cell leukemia cells. Cancer Genet Cytogenet 1988;34:77-88.
22. Takizawa J, Suzuki R, Kuroda H, et al. Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia. Jpn J cancer Res 1998;89:712-8.
23. Hodgson G, Hagar JH, Volik S, et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet 2001;29:459-64.
24. Hakan T, Nigel-PC, Charloytte E, Magnus N, Bruce AJP, Alan T. Degenerated oligonucleotide-primed PCR: General amplification of target DNA by a single degenerated primer. Genomics 1992;13:718-45.
25. Tagawa H, Karnan S, Kasugai Y, et al. MASL1, a candidate oncogene found in amplification at 8p23.1, is translocated in immunoblastic B cell lymphoma cell line OCI-LY8. Oncogene 2004;23:2576-81.
26. Motegi M, Yonezumi M, Suzuki H, et al. AP12-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predicted heterogenous products. Am J Pathol 2000;156:807-12.
27. Kawasaki H, Taira K. Hes1 is a target of microRNAs-23 during retinoic-acid-induced neuronal differentiation of NT2 cells. Nature (Lond.) 2003;423:838-42.
28. Lee RC, Feinbaum RL, Ambros V. The C. elegens heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75:843-54.
29. Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabdtis elegans. Nature (Lond.) 2000;403:901-6.
30. Pasquinelli AE, Reinhart BJ, Slack F, et al. Conservation of the sequence and temporal expression of let-7 hetero chronic regulatory RNA. Nature (Lond.) 2000;408:86-9.
31. Slack FJ, Basson M, Liu Z, Ambros V, Horvitz HR, Ruvkun G. The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between thelet-7 regulatory RNA and the LIN-29 transcriptional factor. Mol Cell 2000;5:659-69.
32. Llave C, Xie Z, Kasschau KD, Carrington JC. Cleavage of Scarecrow-like mRNA targets directed by a class of Arabidopsis miRNA. Science (Wash DC) 2002;297:2053-6.
33. Tang G, Reinhart BJ, Bartel DP, Zamore PD. A biochemical framework for RNA silencing in plants. Genes Dev 2003;17:49-63.
34. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic: leukemia. Proc Natl Acad Sci USA 2002;99:15534-29.